Neural Interfaces for Therapeutic Interventions 2018
In-Person Event
Feb 03, 2018
Los Angeles, California, USAOVERVIEW
Neural Interfaces for Therapeutic Interventions is organized by UCLA Health System and will be held on Feb 03, 2018 at Ronald Reagan UCLA Medical Center, Los Angeles, California, United States of America.
The target audience for this medical event is Neurosurgeons (functional and general), neurologists (general, movement disorder, and epilepsy), psychiatrists, psychologists, pain management physicians, primary care physicians, allied health professionals, and neurosurgery, neurology, and psychiatry residents and fellows. This CME Conference has been approved for a maximum of 6.75 AMA PRA Category 1 Credits.
Course Description :
This comprehensive one-day continuing medical education program in neuromodulation features an outstanding faculty from the Departments of Neurosurgery, Neurology, and Anesthesia at the David Geffen School of Medicine at UCLA. The purpose of the course is to provide an update on the latest multidisciplinary management and application of medical devices for an array of neurologic diagnoses, including movement disorders, epilepsy, chronic pain, and head and facial pain. There will be specific emphasis on new and emerging treatment options, including deep brain stimulation (DBS), responsive neurostimulation, emerging neurotechnologies, and therapies on the horizon. Alternative treatments, including first-line medical management, botulinum toxin therapy, and adjunctive therapies will also be discussed. The course will focus on personalizing therapy, both with respect to patient selection and targeting therapy. To integrate and ensure audience participation, patient testimonials will take place throughout the day. Attendees are encouraged to bring in their own cases for discussion.
Course Objectives :
At the conclusion of this activity, participants should be better able to:
• Describe first line medical therapies for movement disorders, epilepsy and pain
• Understand the role and indications for neuromodulatory treatments
• Understand indications, approaches, and methods for ablative procedures for chronic neurologic conditions
• Describe the multi-modal management of head and facial pain
Additional details will be posted as soon as they are available.
The target audience for this medical event is Neurosurgeons (functional and general), neurologists (general, movement disorder, and epilepsy), psychiatrists, psychologists, pain management physicians, primary care physicians, allied health professionals, and neurosurgery, neurology, and psychiatry residents and fellows. This CME Conference has been approved for a maximum of 6.75 AMA PRA Category 1 Credits.
Course Description :
This comprehensive one-day continuing medical education program in neuromodulation features an outstanding faculty from the Departments of Neurosurgery, Neurology, and Anesthesia at the David Geffen School of Medicine at UCLA. The purpose of the course is to provide an update on the latest multidisciplinary management and application of medical devices for an array of neurologic diagnoses, including movement disorders, epilepsy, chronic pain, and head and facial pain. There will be specific emphasis on new and emerging treatment options, including deep brain stimulation (DBS), responsive neurostimulation, emerging neurotechnologies, and therapies on the horizon. Alternative treatments, including first-line medical management, botulinum toxin therapy, and adjunctive therapies will also be discussed. The course will focus on personalizing therapy, both with respect to patient selection and targeting therapy. To integrate and ensure audience participation, patient testimonials will take place throughout the day. Attendees are encouraged to bring in their own cases for discussion.
Course Objectives :
At the conclusion of this activity, participants should be better able to:
• Describe first line medical therapies for movement disorders, epilepsy and pain
• Understand the role and indications for neuromodulatory treatments
• Understand indications, approaches, and methods for ablative procedures for chronic neurologic conditions
• Describe the multi-modal management of head and facial pain
Additional details will be posted as soon as they are available.
KEY DATES
03 Feb, 2018
Event Start Date
03 Feb, 2018
Event End Date
SPECIALITIES
NeurologySUGGESTED HOTELS
CONFERENCE VENUE
Ronald Reagan UCLA Medical CenterRELATED CONFERENCES & LIVE WEBINARS
Quick Links